Publications by authors named "E Arroyo Palomera"
Aim: The aim was to assess the effectiveness of 23-valent pneumococcal polysaccharide vaccine (PPV23) in preventing CAP in adults.
Methods: This was a population-based cohort study, followed up over 5 years (2015-2019), that included 47,768 persons aged ≥18 years assigned to three primary care centres. Data were retrospectively obtained from electronic medical records and databases.
Objective: Health inequalities are universal, but their magnitude and determinants vary according to geographic areas, and understanding variations is essential to designing and implementing preventive and corrective policies. Our objective was to evaluate health inequalities in the Maresme region (Catalonia, Spain) and the relationship with socioeconomic indicators.
Design: Cross-sectional ecological study (2017).
Article Synopsis
- The study investigates the link between dehydration, muscle breakdown, and sarcopenia in people aged 70 and older.
- It found that a significant number of participants showed dehydration based on plasma osmolarity, and that higher dehydration levels were associated with increased muscle catabolism (indicated by 3-methyl-histidine levels).
- However, contrary to expectations, dehydration was not directly linked to the presence of sarcopenia in these individuals.
Article Synopsis
- The study investigated SARS-CoV-2 antibody levels in healthcare workers (HCW) across four time points from June 2020 to November 2021, highlighting a significant increase in seropositivity over time.
- It found that the seropositivity rate in HCW rose from 11.8% to 28.4%, with high prevalence among nurses and nursing assistants, and identified close contact with COVID-19 cases as a major risk factor.
- Additionally, while 88.8% of HCW were vaccinated, antibody levels decreased significantly post-vaccination, particularly for those who received the Pfizer vaccine compared to Moderna, indicating varying levels of immunity and protection among the workforce.
Article Synopsis
- A study investigated the effectiveness and durability of dual antiretroviral therapy (DAT) in HIV patients in real clinical settings, comparing it to traditional triple-drug regimens.
- Of the 51 patients followed for 48 weeks, 83.8% of those with low viral load and 50% with higher viral load achieved virological suppression, with 76.5% maintaining treatment for an average of about 40 weeks.
- Results showed better adherence and a higher cost for DAT compared to previous regimens, suggesting DAT could be a viable option for patients not responding to triple therapies.